Logo for Liquidia Corp

Liquidia Corp Investor Relations Material

Latest events

Logo for Liquidia Corp

Q3 2023

Liquidia Corp
Logo for Liquidia Corp

Q3 2023

7 Nov, 2023
Logo for Liquidia Corp

Q2 2023

10 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from over 8,000 public companies
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina. It has subsidiary offices throughout North America and Europe.